Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Issue 11 (November 2015) - Murphy, Colin T.
Abstract Highlights Serial imaging permits estimates of tumor-specific growth rate (TSGR) for OPC. Faster TSGR correlates well with p16 status, T-stage and smoking. TSGR predicts outcomes for oropharyngeal cancer (OPC) in the HPV era. TSGR calculation may improve identification of de-escalation candidates.